1,093
edits
Changes
Jump to navigation
Jump to search
Line 1:
Line 1: + + + + + + + + + + + + + + +
DMR Ovariectomy and Butyrate-Enhanced CTA 2 (view source)
Revision as of 09:48, 5 July 2022
, 09:48, 5 July 2022added info box
Test of role of ovarian hormones in butyrate-enhanced CTA. Continuation of [[DMP Ovariectomy and Butyrate-Enhanced CTA]].
Test of role of ovarian hormones in butyrate-enhanced CTA. Continuation of [[DMP Ovariectomy and Butyrate-Enhanced CTA]].
{{Infobox experiment|align=right
| Name = Ovariectomy and Butyrate-Enhanced CTA 2
| project = HDAC Sex Difference
| code = DMR
| protocol = 1917
| funding = Chair's Fund
| investigators = Mukherjee, Houpt
| species = rat
| date = 2022-1-9
| type = CTA
| drugs = butyrate, lithium, estradiol
| artifacts =
| data = https://houptlab.org/bartab/expt/?id=DMR
}}
Dose of NaB based on [https://houptlab.org/papers/pdfs/Houpt065.pdf Kwon and Houpt, Brain Research, 1333 (2010) 36–47], PMID: 20346924 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871962/ PMCID: PMC2871962]
Dose of NaB based on [https://houptlab.org/papers/pdfs/Houpt065.pdf Kwon and Houpt, Brain Research, 1333 (2010) 36–47], PMID: 20346924 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871962/ PMCID: PMC2871962]